Cargando…

SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer

Recurrent inactivating mutations in components of SWI/SNF chromatin-remodeling complexes have been identified across cancer types, supporting their roles as tumor suppressors in modulating oncogenic signaling pathways. We report here that SMARCE1 loss induces EGFR expression and confers resistance t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadakis, Andreas I, Sun, Chong, Knijnenburg, Theo A, Xue, Yibo, Grernrum, Wipawadee, Hölzel, Michael, Nijkamp, Wouter, Wessels, Lodewyk FA, Beijersbergen, Roderick L, Bernards, Rene, Huang, Sidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387553/ https://www.ncbi.nlm.nih.gov/pubmed/25656847 http://dx.doi.org/10.1038/cr.2015.16

Ejemplares similares

A SMARC Effect for Loudness
por: Bruzzi, Elena, et al.
Publicado: (2017)

The Good, the Bad, and the Ugly: in search of gold standards for assessing functional genetic screen quality
por: Evers, Bastiaan, et al.
Publicado: (2014)

A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
por: Šuštić, Tonći, et al.
Publicado: (2018)

Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers
por: Šuštić, Tonći, et al.
Publicado: (2021)

SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1 / ERBB2 co‐amplification
por: Pries, Katharina, et al.
Publicado: (2023)

RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS-mutant colorectal cancer
por: Šuštić, Tonći, et al.
Publicado: (2019)

A multilevel pan-cancer map links gene mutations to cancer hallmarks
por: Knijnenburg, Theo A., et al.
Publicado: (2015)

Smarce1 and Tensin 4 Are Putative Modulators of Corneoscleral Stiffness
por: Boazak, Elizabeth M., et al.
Publicado: (2021)

The Cancer SENESCopedia: A delineation of cancer cell senescence
por: Jochems, Fleur, et al.
Publicado: (2021)

The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence
por: Nijwening, Jeroen H., et al.
Publicado: (2011)

Fewer permutations, more accurate P-values
por: Knijnenburg, Theo A., et al.
Publicado: (2009)

Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR
por: Narayanan, Dilip, et al.
Publicado: (2017)

Targeting the RB-E2F pathway in breast cancer
por: Johnson, Jackie, et al.
Publicado: (2016)

Identifying mutant-specific multi-drug combinations using comparative network reconstruction
por: Bosdriesz, Evert, et al.
Publicado: (2022)

A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
por: Mullenders, Jasper, et al.
Publicado: (2009)

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
por: Korpanty, Grzegorz J., et al.
Publicado: (2014)

EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
por: Colombino, Maria, et al.
Publicado: (2019)

Exploiting combinatorial cultivation conditions to infer transcriptional regulation
por: Knijnenburg, Theo A, et al.
Publicado: (2007)

Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States
por: Navalkele, Pournima, et al.
Publicado: (2020)

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Identification of F-box only protein 7 as a negative regulator of NF-kappaB signalling
por: Kuiken, Hendrik J, et al.
Publicado: (2012)

Multiscale Representation of Genomic Signals
por: Knijnenburg, Theo A., et al.
Publicado: (2014)

A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening
por: Gerkes, E. H., et al.
Publicado: (2016)

smarce1 mutants have a defective endocardium and an increased expression of cardiac transcription factors in zebrafish
por: Castillo-Robles, Jorge, et al.
Publicado: (2018)

High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer
por: Liu, Hao, et al.
Publicado: (2019)

Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
por: Sievers, Philipp, et al.
Publicado: (2020)

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer
por: Zhou, Yangyang, et al.
Publicado: (2022)

MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition
por: Ortiz-Zapater, Elena, et al.
Publicado: (2017)

Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy
por: Knijnenburg, Theo A., et al.
Publicado: (2016)

Combinatorial effects of environmental parameters on transcriptional regulation in Saccharomyces cerevisiae: A quantitative analysis of a compendium of chemostat-based transcriptome data
por: Knijnenburg, Theo A, et al.
Publicado: (2009)

An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation
por: Smit, Linda, et al.
Publicado: (2015)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations
por: Lou, Na-Na, et al.
Publicado: (2016)

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
por: Presutti, Dario, et al.
Publicado: (2015)

Impact of Pre-Analytical Conditions on the Antigenicity of Lung Markers: ALK and MET
por: Miller, Rachel, et al.
Publicado: (2020)

SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway
por: Sethuraman, Aarti, et al.
Publicado: (2016)

miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma
por: Wu, Hong-Jie, et al.
Publicado: (2017)

Negative Correlation Between Circular RNA SMARC5 and MicroRNA 432, and Their Clinical Implications in Bladder Cancer Patients
por: Zhang, Zhijia, et al.
Publicado: (2021)

Comparative Network Reconstruction using mixed integer programming
por: Bosdriesz, Evert, et al.
Publicado: (2018)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

EGFR/Met association regulates EGFR TKI resistance in breast cancer
por: Mueller, Kelly L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l2694i6g02cief1au1n87n7ugf